Quince Therapeutics, Inc. (QNCX)
Nasdaq: QNCX · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2016
Who owns Quince Therapeutics, Inc.
As filed with the SECHolders of 5% or more
8
Group One Trading LLC holds 10.7% of Common Stock, par value $0.0001 par value, as its SCHEDULE 13G filed Mar 5, 2026 says.
Directors and officers
14
report now, of 29 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 8 named at left.
Holders of 5% or moreshare of the class, as filed
Group One Trading LLC
SCHEDULE 13G · filed Mar 5, 2026 · Common Stock, par value $0.0001 par value
Cormorant Asset Management, LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.001 per share
Balyasny Asset Management L.P.
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock
Ikarian Capital, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.001 per share
Perceptive Advisors LLC
SCHEDULE 13G · filed Oct 14, 2026 · Common Stock, par value $0.001 per share
Integrated Core Strategies (US) LLC
SCHEDULE 13G · filed Jun 10, 2026 · Common Stock, par value $0.001 per share
James B. Tananbaum
SCHEDULE 13G · filed Oct 14, 2026 · Common Stock
Squadron Master Fund LP
SCHEDULE 13G · filed Aug 4, 2026 · Common Stock, par value $0.001 per share
Sofinnova Capital VIII
SCHEDULE 13G/A · filed Apr 30, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.4% in Feb 14, 2025
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 7.52% in May 15, 2026
Genextra S.p.A.
SCHEDULE 13G/A · filed Oct 30, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.49% in Feb 18, 2025
What QNCX reports owning in othersstakes of 5% or more, and other ties
7 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 24, 2025.
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$200,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Benatti Luca | director | 1 | $200,000 | 0 | 0 | $0 |